+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cellular LanthaScreen and beta-lactamase reporter assays for high-throughput screening of JAK2 inhibitors



Cellular LanthaScreen and beta-lactamase reporter assays for high-throughput screening of JAK2 inhibitors



Assay and Drug Development Technologies 6(4): 519-529



The Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 5 pathway is responsible for regulation of cellular responses to a number of cytokines and growth factors. In hematopoietic cells, growth factors such as granulocyte macrophage-colony stimulating factor, interleukin-3, and erythropoietin induce the activation of JAK2, which leads to the phosphorylation, dimerization, and transactivation of STAT5 proteins. Dysregulation of JAK2 by activating mutations such as JAK2V617F results in constitutive phosphorylation of STAT5 and has been linked to numerous myeloproliferative disorders such as polycythemia vera. A cellular LanthaScreen (Invitrogen Corp., Carlsbad, CA) time-resolved Förster resonance energy transfer assay for wild-type JAK2 activity was developed. This assay utilized the growth factor-dependent human erythroleukemia TF1 cell line engineered to express a green fluorescent protein-STAT5 fusion protein. Furthermore, a complementary beta-lactamase reporter gene assay was developed to analyze the transcriptional activity of STAT5 downstream of JAK2 in TF1 cells. The same technologies were applied to the development of cellular assays for the interrogation of the disease-relevant JAK2V617F activating mutant. A small molecule inhibitor and Stealth (Invitrogen Corp.) RNA interference oligonucleotides were used to confirm the involvement of JAK2. Our results suggest that these cellular assays and validation tools represent powerful integrated methods for the analysis of physiological and disease-relevant JAK/STAT pathways within the physiological cellular context.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051984833

Download citation: RISBibTeXText

PMID: 18694336

DOI: 10.1089/adt.2008.144


Related references

Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. Analytical Biochemistry 314(1): 16-29, 2003

Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish. Plos one 7(1): E29916, 2012

High-throughput screening using beta-lactamase reporter-gene technology for identification of low-molecular-weight antagonists of the human gonadotropin releasing hormone receptor. Assay and Drug Development Technologies 3(2): 143-154, 2005

Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators. Plos one 4(10): E7655, 2009

Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors. Molecular Pharmacology 72(4): 868-875, 2007

Reporter Assays in the High Throughput Screening Laboratory: A Rapid and Robust First Look?. Journal of Biomolecular Screening 1(3): 115-118, 1996

Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus. Frontiers in Microbiology 8: 2204, 2017

Promoter analysis in mycobacteria using xyl E reporter assays and its implication in high throughput screening. Tuberculosis 81(4): 267-269, 2001

Development of a facile method for high throughput screening with reporter gene assays. Journal of Biomolecular Screening 5(5): 377-384, 2000

Promoter analysis in mycobacteria using xylE reporter assays and its implication in high throughput screening. Tuberculosis 81(4): 267-269, 2001

Selection of an Optimal Reporter Gene for Cell-Based High Throughput Screening Assays. Journal of Biomolecular Screening 2(1): 7-9, 1997

Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Analytical Chemistry 77(16): 5268-5276, 2005

High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system. Methods in Molecular Biology 510: 243-250, 2009

Validation of miniaturized one-step reverse transcription qPCR assays for high-throughput screening and comparison to a reporter gene methodology. Assay and Drug Development Technologies 13(2): 94, 2015

Development of a high-throughput cell-based reporter assay for screening of JAK3 inhibitors. Journal of Biomolecular Screening 16(4): 443-449, 2011